Intressa Vascular announces the start of the EXTENSO clinical study
Intressa Vascular is starting a clinical study to evaluate the effectiveness and safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection (TBAD) in patients eligible for thoracic endovascular repair with stent grafts, the EXtensive mulTilayer stEnt treatmeNt in aortic disSectiOn study, to reduce reinterventions and rupture of the aorta in patients with extended TBAD.
The Allay® Aortic Stent wins the 2024 Prix Galien for Most Promising Design
The Prix Galien, often likened to the Nobel Prize of medical innovation on the international stage, celebrates the most significant advancements in healthcare.
Denis Gestin is appointed to Intressa Vascular Board of Directors
Intressa Vascular SA, a clinical-stage MedTech company using its proprietary multilayer stent braiding technology to develop an innovative stent for aortic dissection, today announces the appointment of Denis Gestin as independent director.
Intressa Vascular secures EUR 13 million in financing
Intressa Vascular secures EUR 13 million in financing to support the development of its innovative multilayer Allay™ Aortic Stent for the treatment of aortic dissection
